Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.9 SEK | +4.12% |
|
+2.96% | +85.33% |
05-27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
05-27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+85.33% | 68.54M | |
+55.19% | 815B | |
+47.26% | 654B | |
-6.09% | 354B | |
+21.92% | 337B | |
+18.40% | 247B | |
+3.64% | 229B | |
+12.98% | 219B | |
+10.86% | 171B | |
-2.78% | 159B |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- Sweden’s IRLAB Therapeutics Names New CEO